<DOC>
	<DOCNO>NCT01574963</DOCNO>
	<brief_summary>Osteoprotegerin ( OPG ) membrane bound immune system also produce secrete almost everywhere organism , mainly available soluble form . So far , OPG/RANKL/RANK system intensively study bone . The binding RANKL receptor RANK , express osteoclast , activate number osteoclastic cell function . OPG also key function vascular system . Patients coronary heart disease ( CAD ) elevate OPG serum level , probably sign ischemic inflammatory endothelial damage . Elevated OPG level also find patient advanced heart failure , whereby OPG correlate pro BNP ( brain natriuretic peptide ) predictor cardiovascular morbidity mortality . Our prospective cohort study include 150 men ( 75 patient require surgery CAD control group without coronary heart disease ) . The primary endpoint difference two group serum level OPG RANKL , marker bone metabolism ( osteocalcin [ OC ] , crosslaps [ CTX ] , tartrate resistant acid phosphatase ( TRAP5b ) , 25 ( OH ) vitamin D [ Vit D ] , 1.25 ( OH ) vitamin D , parathormone [ iPTH ] , endocrine parameter related vascular damage ( e.g . aldosterone , renin cortisol ) bone mineral density . Metabolomic base biomarkers evaluate explore mechanisms behind OPG-RANKL link CVD damage . In patient study mRNA expression OPG , RANKL , TRAP5b , arginine : glycine amidinotransferase ( AGAT ) osteocalcin bone ( sternum sliver ) vascular wall ( aorta , internal thoracic artery great saphenous vein ) perform . A study endpoint analysis causal coincidence osteoporosis CAD discrimination possible key factor two entity . These determined correlation above-mentioned marker serum expression different vessel bone tissue . In addition analysis degree vascular sclerosis , mineral content bone also analyze subpopulation quantitative backscatter electron imaging ( qBEI ) relate degree vascular sclerosis bone mineral density . The ultimate goal analysis discrimination sensitive predictive marker ( ) diagnosis outcome patient CAD purpose early diagnosis primary prevention disease . CAD osteoporosis increasingly prevalent disease overlap . In entity , OPG play role pathogenesis also outcome predictor . We aim study relevance OPG concentration serum also vessel wall bone .</brief_summary>
	<brief_title>Graz Osteoprotegerin Risk Factor ( GORF ) Study</brief_title>
	<detailed_description />
	<criteria>Male patient 40 year age present symptomatic CAD schedule coronary artery bypass graft ( CABG ) eligible study . The control group include male patient schedule elective surgery cardiac procedure . Exclusion criterion second indication heart surgery , chronic renal disease glomerular filtration rate &lt; 30ml/min , advance liver disease ( AST , ALT , GGT &gt; 3fold upper limit normal ) , history malignancy within last 5 year ongoing osteoprotective treatment .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>OPG</keyword>
	<keyword>RANKL</keyword>
	<keyword>bone disease</keyword>
</DOC>